Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack An Updated Systematic Review and Meta-Analysis
Publication in refereed journal

Times Cited
Web of Science76WOS source URL (as at 10/09/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractBackground Emerging studies suggest that early administration of dual antiplatelet therapy may be better than monotherapy for prevention of early recurrent stroke and cardiovascular outcomes in acute ischemic stroke and transient ischemic attack (TIA). We performed a meta-analysis of randomized, controlled trials evaluating dual versus mono antiplatelet therapy for acute noncardioembolic ischemic stroke or TIA.
All Author(s) ListWong KSL, Wang YL, Leng XY, Mao C, Tang JL, Bath PMW, Markus HS, Gorelick PB, Liu LP, Lin WH, Wang YJ
Journal nameCirculation
Volume Number128
Issue Number15
PublisherAmerican Heart Association
Pages1656 - 1666
LanguagesEnglish-United Kingdom
Keywordsantiplatelet agents; meta-analysis; review; stroke; systematic; transient ischemic attack
Web of Science Subject CategoriesCardiac & Cardiovascular Systems; CARDIAC & CARDIOVASCULAR SYSTEMS; Cardiovascular System & Cardiology; Peripheral Vascular Disease; PERIPHERAL VASCULAR DISEASE

Last updated on 2020-11-09 at 00:20